Effects of vitamin C on arylamine N-acetyltransferase activity in human liver tumor cells

Anticancer Res. 1998 Sep-Oct;18(5A):3481-6.

Abstract

Arylamine N-acetyltransferase (NAT) activity in a human liver tumor (heptoma) cell line was inhibited by vitamin C. Using high performance liquid chromatography, NAT activity on the acetylation of 2-aminofluorene and p-aminobenzoic acid was examined. Two assay systems were performed, one with cellular cytosols, the other with intact liver tumor cell suspensions. The NAT activity in a human liver tumor cell line was inhibited by vitamin C in a dose-dependent manner in both types of examined system: i.e. the greater the concentration of vitamin C in the reaction, the greater the inhibition of NAT activities in both systems examined. The data also indicated that vitamin C decreased the apparent Km and Vmax of NAT enzymes from human liver tumor cells in both systems examined. This report is the first demonstration which showed vitamin C effect on human liver tumor cell NAT activity.

MeSH terms

  • 4-Aminobenzoic Acid / metabolism
  • Acetylation
  • Arylamine N-Acetyltransferase / metabolism*
  • Ascorbic Acid / administration & dosage
  • Ascorbic Acid / pharmacology*
  • Carcinogens / metabolism
  • Cytosol / metabolism
  • Dose-Response Relationship, Drug
  • Fluorenes / metabolism
  • Humans
  • Liver Neoplasms / enzymology*
  • Neoplasm Proteins / metabolism*
  • Tumor Cells, Cultured / enzymology

Substances

  • Carcinogens
  • Fluorenes
  • Neoplasm Proteins
  • 2-aminofluorene
  • Arylamine N-Acetyltransferase
  • Ascorbic Acid
  • 4-Aminobenzoic Acid